Form 4: Myriad Genetics Chief Scientific Officer Sells Shares to Cover Tax Obligations

Myriad Genetics' Chief Scientific Officer, Dale Muzzey, sold 417 shares of common stock on January 1, 2025, to cover tax obligations related to vesting restricted stock units.

Summary

• Dale Muzzey, the Chief Scientific Officer of Myriad Genetics, sold 417 shares of common stock on January 1, 2025.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The price per share was $13.71.
• Following the transaction, Mr. Muzzey directly owns 107,144 shares of Myriad Genetics common stock.

Sentiment

Score: 5

Explanation: This is a neutral event, a routine transaction for tax purposes, and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The number of shares sold is relatively small compared to the total holdings of the executive, which is typical for these types of transactions.
• The price of $13.71 is the market price at the time of the transaction, which is standard practice.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale by an executive for tax purposes.

Key Dates

Keywords

Myriad Genetics, insider trading, Form 4, stock sale, restricted stock units, tax obligations, Dale Muzzey, Chief Scientific Officer